After more than 15 years, the battle between the Canada Revenue Agency and Glaxo Canada over the transfer price for ranitidine—the active pharmaceutical ingredient used to make the branded, anti-ulcer drug Zantac—finally reached the Supreme Court of Canada (SCC) last month.
CRA named Top 3 Litigation Dispute Advisory Services Consultant in The National Law Journal
CRA’s Chicago Practice is proud to have been ranked as one of the Top 3 Litigation Dispute Advisory Services Consultancies in The National Law Journal’s “Best...